Rising Alcohol Consumption Driving Market Growth Due To Increasing Health Risks: A Significant Driver Propelling The Liver Cancer Market In 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Liver Cancer Market Size and Projected Growth Rate?
In recent years, there has been significant growth in the liver cancer market. Forecasted to expand from $2.94 billion in 2024 to $3.37 billion in 2025, it is expected to witness a compound annual growth rate (CAGR) of 14.5%. This historical growth can be linked to several factors including a global rise in liver cancer cases, an increase in hepatitis B and C infections, a surge in non-alcoholic fatty liver disease, government policies encouraging early detection, and heightened public awareness about liver health.

The market size for liver cancer is anticipated to experience swift expansion in the forthcoming years. The market value is projected to reach $5.75 billion in the year 2029 with a considerable compound annual growth rate (CAGR) of 14.3%. Various factors contributing to this growth during the forecast period include an increasing aging population, escalated healthcare spending, a surging demand for less invasive treatments, an expansion in the count of specialty clinics, and a boost in medical tourism. Some significant trends set to shape the forecast period consist of enhancements in diagnostic technologies, developments in the design of targeted therapies, the inception of combination therapies, technological progress in surgical procedures, and improvements in radiotherapy techniques.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22039

What Are the Major Segments in the Liver Cancer Market?
The liver cancer market covered in this report is segmented -

1) By Type: Hepatoblastoma, Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma, Fibrolamellar Carcinoma
2) By Stage Of Liver Cancer: Early Stage, Intermediate Stage, Advanced Stage
3) By Treatment: Targeted Therapy, Radiation Therapy, Surgery, Chemotherapy, Immunotherapy
4) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Research Institutes

Subsegmentss:

1) By Hepatoblastoma: Epithelial Hepatoblastoma, Mixed Epithelial and Mesenchymal Hepatoblastoma
2) By Intrahepatic Cholangiocarcinoma: Mass-forming Cholangiocarcinoma, Periductal Infiltrating Cholangiocarcinoma, Intraductal Growing Cholangiocarcinoma
3) By Hepatocellular Carcinoma: Fibrolamellar Hepatocellular Carcinoma, Conventional Hepatocellular Carcinoma, Scirrhous Hepatocellular Carcinoma, Clear Cell Hepatocellular Carcinoma, Lymphoepithelioma-like Hepatocellular Carcinoma
4) By Fibrolamellar Carcinoma: Classic Fibrolamellar Carcinoma, Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22039&type=smp

What Are The Driving Liver Cancer Market Evolution?
The liver cancer market is anticipated to experience growth, propelled by the rise in alcohol intake. Alcohol consumption, which denotes the frequency and quantity of alcoholic beverage intake, is on the rise. More people are turning to alcohol as a means of coping with daily stress, facilitating social interactions at gatherings, and amplifying moments of relaxation, largely due to its increased promotion in media and accessibility in various environments. However, high levels of alcohol intake can result in liver cirrhosis, inflammation, and DNA damage, thereby heightening the chances of liver cancer by triggering anomalous cell growth. For instance, the National Drugs Library, an Irish data collection organization, reported in March 2023 that the average alcohol consumption for individuals over 15 years old in 2022 increased to 10.2 liters of pure alcohol per head, indicating a 7.6% rise from the previous year. Consequently, the upward trend in alcohol consumption fuels the liver cancer market.

Which Firms Dominate The Liver Cancer Market Segments?
Major companies operating in the liver cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Siemens Healthineers AG, Terumo Corporation, Eisai Co. Ltd., Qiagen N.V., Exelixis Inc., BeiGene Ltd., RayzeBio Inc., Innovent Biologics Inc., Celsion Corporation

What Trends Are Expected to Dominate the Liver Cancer Market in the Next 5 Years?
Leading firms in the liver cancer market are prioritizing the creation of novel therapy devices that facilitate transcatheter arterial chemoembolization (TACE) with the goals of boosting treatment accuracy, bettering patient results, and minimizing adverse effects. TACE is a less invasive method that administers chemotherapy straight to a liver tumor and simultaneously disrupts its blood supply to boost the efficiency of the treatment. For example, in November 2023, Terumo Corporation, a medical technology firm based in Japan, introduced Occlusafe and LifePearl, therapy devices which have been developed for successful liver cancer treatment. These instruments are intended to improve the handling of liver cancer, especially hepatocellular carcinoma (HCC) - the most prevalent type of primary liver cancer in India - with over 20,000 novel occurrences documented yearly. Occlusafe is a component of a sophisticated treatment named Balloon-TACE (B-TACE), which amplifies the precision and efficiency of TACE by using a balloon to obstruct blood flow during the process. LifePearl are polyethylene glycol (PEG) embolization microspheres that have the capability to be packed with chemotherapeutic substances.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-cancer-global-market-report

Which Is The Largest Region In The Liver Cancer Market?
North America was the largest region in the liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Cancer Market?
2. What is the CAGR expected in the Liver Cancer Market?
3. What Are the Key Innovations Transforming the Liver Cancer Industry?
4. Which Region Is Leading the Liver Cancer Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.